findmyKOL

Catherine Koss, MD

Basic profile

University of California, San Francisco

ORCIDNPI
RegionSan Francisco, CA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2018–2026Why? →

Catherine Koss is an Infectious Disease physician affiliated with University of California, San Francisco. OpenAlex indexes 59 publications with 2,128 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
59publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,128citations

Total citations across indexed works.

27h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
4NIH grants · 2018–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Ucsf Department Of Medicine
505 Parnassus Avenue
San Francisco, CA 941430001

Telephone

415-476-1528

Provider last certified this registry record 13 May 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    28.1%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor11.1%
    Tivicay69%Isentress11%Cabenuva10%Dovato10%
    Part D<11 patients
    Protease Inhibitor7.3%
    Darunavir48%Ritonavir37%Prezcobix15%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    28%
    Statin8.6%
    Atorvastatin Calcium100%
    Part D13 patients
    Beta blocker4.6%
    Metoprolol Succinate100%
    Part D<11 patients

    + 7 more classes in this area

  • Nervous system

    22.3%
    Opioid Agonist6.8%
    Oxycodone Hcl59%Morphine Sulfate Er41%
    Part D<11 patients
    Gabapentinoids4.3%
    Gabapentin100%
    Part D<11 patients

    + 4 more classes in this area

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 20182026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”